RA Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

RA Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.8M	Hold	2,600,000	–	–	0.41%	40
2025 Q4	$65M	Buy	+2,600,000	New	+$46.3M	0.67%	31
2022 Q3	–	Sell	-233,793	Closed	-$952K	–	93
2022 Q2	$952K	Sell	233,793 -270,712	-54%	-$859K	0.03%	85
2022 Q1	$2.15M	Sell	504,505 -1,645,899	-77%	-$9.07M	0.05%	94
2021 Q4	$20.1M	Hold	2,150,404	–	–	0.35%	60
2021 Q3	$59.3M	Hold	2,150,404	–	–	0.82%	37
2021 Q2	$60.2M	Hold	2,150,404	–	–	0.97%	29
2021 Q1	$71.3M	Hold	2,150,404	–	–	1.08%	30
2020 Q4	$103M	Buy	+2,150,404	New	+$101M	1.45%	21

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

RA Capital Management's OLMA Position: Q1 2026 in Review

RA Capital Management held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 2,600,000 shares worth $38.8M. The position accounts for 0.41% of the portfolio, ranked #40.

RA Capital Management first reported a position in OLMA in Q4 2020 and has held it in 9 quarters since. The position peaked at $103M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

RA Capital Management held 2,600,000 shares of Olema Pharmaceuticals worth $38.8M as of Q1 2026.
RA Capital Management left its Olema Pharmaceuticals share count unchanged in Q1 2026.
Olema Pharmaceuticals made up 0.41% of RA Capital Management's portfolio in Q1 2026, its #40 holding.
RA Capital Management first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
RA Capital Management's Olema Pharmaceuticals position peaked at $103M in Q4 2020.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on RA Capital Management's 13F filing for Q1 2026, filed 15 May 2026.